Program Modules


1. An overview and introduction to Cannabis: Charles Pollack, MD (length of module 18:58)

Objectives for the learner, who upon completion should be able to:

-- Describe the history of cannabis use

-- Explain US marijuana regulatory history and current status

-- Distinguish marijuana from hemp

-- Identify the differences among types of cannabinoids (phytocannabinoids, synthetic cannabinoids, endocannabinoids)

2. The Endocannabinoid System: Charles Pollack, MD; Sara Jane Ward, PhD; Stephen Silberstein, MD; Eric Marsh, MD, PhD (length of module 45:43)

Objectives for the learner, who upon completion should be able to:

-- Define endocannabinoids and discriminate between endo- and exogenous cannabinoids

-- Describe the functions of the endocannabinoid system

-- Discuss CB1 and CB2 receptors and differentiate between them

3. Medicinal cannabis safety, cannabis-drug interactions, cannabis in cancer care and palliative care:   Charles Pollack, MD; Sara Jane Ward, PhD; Stephen Silberstein, MD; David Casarett, MD; Brooke Worster, MD; Rachel Schepart, RPh (length of module 46:24)

Objectives for the learner, who upon completion should be able to:

-- Discuss the safety of medicinal cannabis, and compare with alternative therapies

-- Discuss selected conditions for which medicinal cannabis is approved in Pennsylvania

-- Review medicinal cannabis use in palliative care and cancer

-- Identify important drug-drug interactions between medical cannabis and other medications

4. Medicinal cannabis in pain management: Charles Pollack, MD; Eugene Viscusi, MD; Mark Ware, MBBS, MRCP; William Jangro, DO (length of module 39:07)

Objectives for the learner, who upon completion should be able to:

-- Describe the complexities of classifying pain

-- Review the use of medicinal cannabis in the management of different types of pain, and identify situations when medicinal cannabis may be recommended.

-- Discuss potential co-administration or overlap of medical cannabis with opioids in the management of pain

5. Misuse, abuse, and addiction:  Charles Pollack, MD; Eugene Viscusi, MD; Mark Ware, MBBS, MRCP; William Jangro, MD; Brooke Worster, MD (length of module 40:38)

Objectives for the learner, who upon completion should be able to:

-- Define cannabis use disorder and name 2 symptoms of cannabis use disorder

-- Explain the association between cannabis use and mental health disorders

-- Identify strategies for assessing patients with cannabis use disorder

-- Review treatment options for patients with cannabis use disorder

6. Current research in medical cannabis: Program wrap-up: Charles Pollack, MD; Deb Hasin, PhD; Brooke Worster, MD (length of module 25:38)

Objectives for the learner, who upon completion should be able to:

-- Review the findings of current epidemiological studies

-- Discuss general guidelines for responsible medicinal cannabis use by patients